Abstract
In Chapter IV.A of this volume we deal in more detail with the kinetics of the interaction of antihistaminics with the so-called H1 receptors for histamine. In the present subchapter we will study general aspects of that interaction, having in view the possibility of developing a general theory that might embody the interaction of agonists (including cholinomimetics) and antagonists with receptors, from a thermodynamic standpoint.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahmed, A., Marshall, P.B.: Relationship between antiacetylcholine and anti-Tremorine activity in antiparkinsonian and related drugs. Brit. J. Pharmacol. 18, 247–254 (1962).
Ariëns, E.J.: Molecular Pharmacology, Vol. 1. New York: Academic Press 1964.
Ariëns, E. J., van Rossum, J. M., Koopman, P.: Receptor reserve and threshold phenomena. I. Theory and experiments with autonomic drugs tested on isolated organs. Arch. int. Pharmaco-dyn. 127, 459–78 (1960).
Ariëns, E. J., Simonis, A. M.: Cholinergic and anticholinergic drugs, do they act on common receptors? Ann. N.Y. Acad. Sci. 144, 842–867 (1967).
Arunlakshana, O., Schild, H.O.: Some quantitive uses of drug antagonism. Brit. J. Pharmacol. 14, 48–58 (1959).
Bareicha, L., Rocha e Silva, M.: Occurrence of H2-receptors for histamine in the guinea-pig intestine. Biochem. Pharmacol. 24, 1215–1219 (1975).
Barlow, R.B.: Chemical Pharmacology, 2nd Ed. London: Methuen 1964.
Belleau, B.: Water as the determinant of thermodynamic transitions in the interaction of aliphatic chains with acetylcholinesterase and the cholinergic receptors. Ann. N.Y. Acad. Sci. 44, 705–717(1967).
Beraldo, W.T., Rocha e Silva, M.: Biological assay of anti-histaminics, atropine and antispasmodics upon the guinea-pig gut. J. Pharmacol. exp. Ther. 97, 388–398 (1949).
Bloom, B.M., Goldman, I. M.: The nature of catecholamine—adenine mononucleotide interaction in adrenergic mechanisms. Advanc. Drug Res. 3, 121–169 (1966).
Bucher, K.: Zum Wirkungsmechanismus der Antihistaminica. Helv. physiol. Acta 7, 315–320 (1949 a).
Bucher, K.: Zum Wirkungsmechanismus der Antihistaminica. Arch. int. Pharmacodyn. 79, 336–342 (1949b).
Burgen, A. S.V.: Role of ionic interaction at the muscarinic receptor. Brit. J. Pharmacol. 25, 4–17(1965).
Cambridge, G.W., Holgate, J.A.: Superfusion as a method for the study of drug antagonism. Brit. J. Pharmacol. 10, 326–335 (1955).
Changeux, J.P.: Properties of the cholinergic receptor protein from fish eletric organs and its purified membrane bound forms. Abstracts VI Intern. Congr. Pharmacology (Helsinki) p. 1135 (1975).
Clark, A.J.: General Pharmacology. Hdb. exp. Pharmakol., Vol.4, pp. 1–228 (1937). Reprinted. Berlin-Heidelberg-New York: Springer 1970.
Cohen, J. B., Changeux, J.P.: Interaction of a fluorescent ligand with membrane-bound cholinergic receptors from Torpedo marmorata. Biochemistry 12, 4855–4863 (1973).
Cohen, J.B., Changeux, J.P.: The cholinergic receptor protein in its membrane environment. Ann. Rev. Pharmacol. 15, 83–103 (1975).
Colquhoun, D.: How long does a molecule stay on the receptor? Explanation of a paradox. Brit. J. Pharmacol. 39, 215–216 P (1970).
Cook, D. A.: The absence of a significant histamine receptor reserve in vascular smooth muscle. J. Pharm. Pharmacol. 22, 63–64 (1970).
Cook, D. A.: Blockade by phenoxybenzamine of the contractor response produced by agonists in the isolated ileum of the guinea-pig. Brit. J. Pharmacol. 43, 197–209 (1971).
Cuatrecasas, P.G., Tell, P.E., Sica, V., Parikh, I., Chang, K.J.: Noradrenaline binding and the search for catecholamine receptors. Nature (Lond.) 247, 92–97 (1974).
De Robertis, E.: Molecular biology of synaptic receptors. Science 171, 963–971 (1971).
De Robertis, E.: Isolation and molecular properties of receptor proteins for neuroactive drugs. In: Mano, E.B. (Ed.): Proc. Symp. on Macromolecules, Rio de Janeiro, pp.349–369 (1975).
De Robertis, E., Plazas, S.F., Ochoa, E.: Adrenergic receptors: isolation and molecular properties. Advanc. Cytopharmacol. 2, 5–21 (1974).
Dixon, M., Webb, E. C.: Enzymes. New York: Academic Press 1958.
Dupont, Y., Cohen, J.B., Changeux, J.P.: X-ray diffraction of membrane fragments rich in acetylcholine receptor protein prepared from the electric organ Torpedo marmorata. FEBS Letters 40, 130–133(1974).
Everett, D.H.: An Introduction to the Study of Chemical Thermodynamics. Edinburgh: Longmans, Green and Co. Ltd. 1962.
Fastier, F.N., Reid, C. S.W.: Influence of chain length upon some pharmacological properties of S-alkyl isothioureas. Brit. J. Pharmacol. 7, 417–432 (1952).
Ferguson, J.: The use of chemical potentials as indices of toxicity. Proc. roy. Soc. B 127, 387 – 404(1939).
Furchgott, R.F.: The pharmacology of vascular smooth muscle. Pharmacol. Rev. 7, 183–265 (1955).
Furchgott, R.F.: Receptor mechanisms. Ann. Rev. Pharmacol. 4, 21–50 (1964).
Furchgott, R.F.: The pharmacological differentiation of adrenergic receptors. Ann. N.Y. Acad. Sci. 139, 553–570(1967).
Furchgott, R. F., Bursztyn, P.: Comparison of dissociation constants and of relative efficacies of selected agonists acting on parasympathetic receptors. Ann. N.Y. Acad. Sci. 144, 882–899 (1967).
Furchgott, R.F., Jurkiewicz, A., Jurkiewicz, N. H.: Antagonism of propranolol to isoproterenol in guinea-pig trachea: some cautionary findings. In: Usdin, E., Snyder, S. (Eds.): Frontiers in Catecholamine Research, pp.295–299. Oxford: Pergamon Press 1973.
Garcia Leme, J., Rocha e Silva, M.: Competitive and non-competitive inhibition of bradykinin on the guinea-pig ileum. Brit. J. Pharmacol. 25, 50–58 (1965).
Gosselin, R.E.: Drug receptor inactivation: a new kinetic model. Brit. J. Pharmacol. 39, 215 P (1970).
Graham, J. D. P., Al Katib, H.: The action of trypsin on blockade by 2-halogenoalkylamines: speculation on the nature of the alpha receptor for catecholamines. Brit. J. Pharmacol. 28, 1–14(1966).
Ison, R.R., Casy, A.F.: Structural influences upon antihistamine activity: 3-amino-l-aryl-1-(2-pyridyl)propenes and related compounds. J. Pharm. Pharmacol. 23, 848–856 (1971).
Ison, R.R., Franks, F.M., Soh, K.S.: The binding of conformationally restricted antihistamines to histamine receptors. J. Pharm. Pharmacol. 25, 887–849 (1973).
Kauzmann, N.: Some factors in the interpretation of protein denaturation. Advanc. Protein Chem. 14, 1–63 (1959).
Korolkovas, A., Tamashiro, K.: Farmacologia quântica. I. Transferência de carga na complexação de antagonistas com receptores farmacológicos. Ciência e Cultura 26, 498–499 (1974).
Koshland, D.E.: Conformation changes at the active site during enzyme action. Fed. Proc. 23, 719–726 (1964). See also Discussion Fed. Proc. 27, 907–913 (1968).
Lineweaver, H., Burk, D.: The determination of enzyme dissociation constants. J. Amer. chem. Soc. 56, 658–666(1934).
Mares-Guia, M, Rezende, Jr., L., Diniz, C.R.: Interaction of histamine and phenylguanidine with the histamine receptor in the isolated guinea-pig ileum. A new model for the histamine receptor. In: Symposium on Receptors and Active Centers of Enzymes. Sociedade Brasileira de Farmacologia e Terapeutica Experimental, Belo Horizonte. Abstracts p. 38 (1975).
Marshall, P. B.: Some chemical and physical properties associated with histamine antagonism. Brit. J. Pharmacol. 10, 270–278 (1955a).
Marshall, P. B.: Antagonism of acetylcholine by (+) and (-)hyoscyamine. Brit. J. Pharmacol. 10, 354–355 (1955 b).
Mautner, H.G.: The molecular basis of drug action. Pharmacol. Rev. 19, 107–144 (1967).
Moran, J.F., Triggle, C.R., Triggle, D. J.: The mechanisms of action of 2-halogenoethylamines at the adrenergic α-receptor and a further investigation of the “spare receptors” hypothesis. J. Pharm. Pharmacol. 21, 38–46 (1969).
Moran, J.F., Triggle, D.J.: Fundamental Concepts in Drug-Receptor Interactions. New York: Academic Press 1970.
Nickerson, M.: Receptor occupancy and tissue response. Nature (Lond.) 176, 697–698 (1956).
Nickerson, M.: Nonequilibrium drug antagonism. Pharmacol. Rev. 9, 246–259 (1957).
Ochoa, E., Llorente-de-Carlin, M.C., De Robertis, E.: Isolation of a proteolipid binding 3H-isoproterenol from the heart ventricle of the cat. Europ. J. Pharmacol. 18, 367–374 (1972).
Parker, R.B., Waud, D.R.: Pharmacological estimation of drug-receptor dissociation constants. Estatistical evaluation. I. Agonists. J. Pharmacol. exp. Ther. 177, 1–12 (1971).
Paton, W.D.M.: A theory of drug action based on the rate of drug-receptor combination. Proc. roy. Soc. B 154, 21–69 (1961).
Paton, W.D.M., Rang, H.P.: The uptake of atropine and related drugs by intestinal smooth muscle of the guinea-pig in relation to acetylcholine receptors. Proc. roy. Soc. B 163, 1–44 (1965).
Paton, W.D.M., Waud, D.R.: A quantitative investigation of the relationship between rate of access of a drug to receptor and the rate of onset or offset of action. Arch. Exp. Path. Pharmakol. 248, 124–143 (1964).
Rang, H. P.: The kinetics of action of acetylcholine antagonists in smooth muscle. Proc. roy. Soc. B 164, 488–510(1966).
Rang, H.P.: Receptor mechanisms. Brit. J. Pharmacol. 48, 475–495 (1973a).
Rang, H.P. (Ed.): Drug Receptors. London: MacMillan 1973b.
Rocha e Silva, M.: Inhibition of histamine effects by compounds of histamine, histidine and arginine. J. Pharmacol. exp. Ther. 80, 399–408 (1944).
Rocha e Silva, M.: The mechanism of recovery of the guinea-pig gut from inhibition by atropine and anti-histaminics. Exp. Med. Surg. 8, 346–356 (1950).
Rocha e Silva, M.: Kinetics of recovery from inhibition by anti-histaminics, atropine and antispasmodics. Pharmacol. Rev. 9, 259–264 (1957).
Rocha e Silva, M.: Concerning the theory of receptors in pharmacology. A rational method of estimation of pAx. Arch. int. Pharmacodyn. 118, 74–94 (1959).
Rocha e Silva, M.: Influence of pH on the interaction of histamine with its receptors in the guinea-pig ileum. Arch. int. Pharmacodyn. 128, 355–374 (1960).
Rocha e Silva, M.: On the nature of the receptors for histamine. Chemoterapia 3, 544–559 (1961).
Rocha e Silva,M.: Antagonistas da bradicinina. Tese, Faculdade de Medicina de Ribeirão Pre-to,USP(1963).
Rocha e Silva, M.: Action of histamine in smooth muscle. Heffter’s Handb. Exptl. Pharmakol. 18/1, 225–237(1966).
Rocha e Silva, M.: A thermodynamic approach to problems of drug interaction. I. The “Charnière theory”. Europ. J. Pharmacol. 6, 294–302 (1969).
Rocha e Silva, M.: A thermodynamic approach to problems of drug antagonism. A microphysical model of the phenomenon of recovery. Physiol, chem. Phys. 2, 503–515 (1970).
Rocha e Silva, M.: A thermodynamic approach to problems of drug antagonism: the microphysical model. In: Rocha e Silva, M., Suarez-Kurtz, G. (Eds.): Concepts of Membranes in Regulation and Excitation, pp. 181–192. New York: Raven Press 1975a.
Rocha e Silva, M.: Mini-Review concerning the presence of “spare receptors” for histamine in the guinea-pig ileum and in other smooth muscle structures. Gen. Pharmacol. 6, 259–267 (1975 b).
Rocha e Silva, M., Beraldo, W.T.: Dynamics of recovery and measure of drug antagonism. Inhibition of smooth muscle by lysocithin and anti-histaminics. J. Pharmacol. exp. Ther. 93, 457–469 (1948 a).
Rocha e Silva, M., Beraldo, W.T.: Effect of cations upon recovery of the guinea-pig gut from inhibition by anti-histaminics. Science 108, 162–163 (1948 b).
Rocha e Silva, M., Fernandes, F., Antonio, A.: Influence of temperature on recovery of inhibition by anti-histaminics and β-haloalkylamines toward histamine. Europ. J. Pharmacol. 17, 333–340(1972).
Rocha e Silva, M., Fernandes, F.: Determination of the parameters of affinity (pA2) in different temperatures. A thermodynamic approach. Europ. J. Pharmacol. 25, 231–240 (1974).
Rocha e Silva, M., Garcia-Leme, J.: On some antagonists of bradykinin. Arch. exp. Path. Pharmakol. 250, 167–170 (1965a).
Rocha e Silva, M., Garcia Leme, J.: Antagonists of bradykinin. 2nd. Internat. Pharmacol. Meet. (Prague) 1963. Proc. 9, 33–42 (1965 b) Oxford: Pergamon Press.
Rossini, F.D.: Chemical Thermodynamics. New York: John Wiley & Sons 1950.
Schild, H.O.: pA, a new scale for the measurement of drug antagonism. Brit. J. Pharmacol. 2, 189–200(1947).
Singer, S. J.: The structure and function of membranes. Panam. Ass. Biochem. Sci. 2, 485–491 (1973).
Steinberg, I. Z., Sheraga, H.A.: Entropy changes accompanying association reactions of proteins. J. biol. Chem. 238, 172–181 (1963).
Stephenson, R.P.: A modification of receptor theory. Brit. J. Pharmacol. 11, 379–393 (1956).
Takagi, K., Uchida, M.: Purification of histamine receptor in cat small intestinal muscle. I. Specificity of labeling histamine receptor with radioactive dibenamine. Jap. J. Pharmacol. 20, 272–286 (1970).
Thron, C.D.: Graphical and weighted regression analyses for the determination of agonist dissociation constants. J. Pharmacol. exp. Ther. 175, 541–553 (1970).
Vogt, W.: Pharmacologically active substances formed in egg yolk by cobra venom. J. Physiol. (Lond.) 136, 131–147(1957).
Waud, D.R.: Pharmacological receptors. Pharmacol. Rev. 20, 49–88 (1968).
Waud, D.R., Parker, R.B.: Pharmacological estimation of drug-receptor dissociation constants. II. Competitive antagonists. J. Pharmacol. exp. Ther. 177, 13–24 (1971).
Wilbrandt, W.: Zur Frage des Wirkungsmechanismus der Anti-Histaminsubstanzen. Helv. physiol. Acta 8, 399–408 (1950).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Rocha e Silva, M. (1978). Kinetics of Antagonist Action. In: Rocha e Silva, M. (eds) Histamine II and Anti-Histaminics. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 18 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66445-8_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-66445-8_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66447-2
Online ISBN: 978-3-642-66445-8
eBook Packages: Springer Book Archive